Download PDF
J Reconstr Microsurg 2006; 22(8): 641-647
DOI: 10.1055/s-2006-956238
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Proinflammatory Cytokines Gene Expression in Skin Flaps with Arterial and Venous Ischemia in Rats

Feng Zhang1 , Eric C. Hu1 , Shelby Topp1 , Manping Lei1 , Weijia Chen1 , William C. Lineaweaver1
  • 1Division of Plastic Surgery, University of Mississippi Medical Center, Jackson, Mississippi
Further Information

Publication History

Accepted: May 17, 2006

Publication Date:
30 November 2006 (online)

    Permissions and Reprints

ABSTRACT

Infiltration of inflammatory cells is the crucial element in ischemia-reperfusion injury of the microsurgical flap. Cytokines are a large functional group of polypeptide regulatory molecules that influence the activity of various cell types through autocrine and paracrine mechanisms. In this study, expression of selected proinflammatory cytokines was examined in skin flaps with arterial and venous ischemia in the rat model. Fifty-four Sprague-Dawley rats were used in the study. The ischemia of each flap was induced by clamping its vascular pedicle for 6 hr. The flap was then replaced and allowed to reperfuse. All flaps were biopsied immediately post-event, and at 3, 6 and 18 hr after reperfusion. Expression of tumor necrosis factor (TNF-α), interleukin (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) mRNA was determined by RT-PCR in each case. The same number of skin flaps without ischemia was used for baseline gene expression. Results showed that the TNF-α expression was significantly up-regulated in the flaps with arterial ischemia at 6 hr after reperfusion. In the flaps with venous ischemia, MCP-1 expression was increased with its peak expression at 3 hr after reperfusion. IL-1β expression was increased threefold in the flaps subjected to venous ischemia and following reperfusion in 3 hr, but the peak expression in the flap with arterial ischemia was observed at 18 hr after reperfusion. This study delineated the changes in expression of these proinflammatory cytokines in flaps with arterial and venous ischemia reperfusion injury, and showed that cytokine expression was different in the arterial and venous injuries.

KEYWORDS

Surgical flap - cytokine - skin - ischemia

REFERENCES

  • 1 Kako K J. Free radical effects on membrane protein in myocardial ischemia/reperfusion injury.  J Mol Cell Cardiol. 1987;  19 209-211
    CrossrefPubMedGoogle Scholar
  • 2 Kerrigan C L, Stotland M A. Ischemia reperfusion injury: a review.  Microsurgery. 1993;  14 165-175
    CrossrefPubMedGoogle Scholar
  • 3 Jordan J E, Zhao Z Q, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury.  Cardiovasc Res. 1999;  43 860-878
    CrossrefPubMedGoogle Scholar
  • 4 Smith J K, Grisham M B, Granger D N et al.. Free radical defense mechanisms and neutrophil infiltration in postischemic skeletal muscle.  Am J Physiol. 1989;  256 H789-H793
    PubMedGoogle Scholar
  • 5 Lee C, Kerrigan C L, Tellado J M. Altered neutrophil function following reperfusion of an ischemic myocutaneous flap.  Plast Reconstr Surg. 1992;  89 916-923
    PubMedGoogle Scholar
  • 6 Schlag M G, Harris K A, Potter R F. Role of leukocyte accumulation and oxygen radicals in ischemia-reperfusion-induced injury in skeletal muscle.  Am J Physiol Heart Circ Physiol. 2001;  280 H1716-H1721
    PubMedGoogle Scholar
  • 7 Ono S J, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function.  J Allergy Clin Immunol. 2003;  111 1185-1199
    CrossrefPubMedGoogle Scholar
  • 8 Stadelmann W K, Digenis A G, Tobin G R. Physiology and healing dynamics of chronic cutaneous wounds.  Am J Surg. 1998;  176 26S-38S
    CrossrefPubMedGoogle Scholar
  • 9 Steed D L. The role of growth factors in wound healing.  Surg Clin North Am. 1997;  77 575-586
    CrossrefPubMedGoogle Scholar
  • 10 Kubo T, Yano K, Hosokawa K. Management of flaps with compromised venous outflow in head and neck microsurgical reconstruction.  Microsurgery. 2002;  22 391-395
    CrossrefPubMedGoogle Scholar
  • 11 Angel M F, Mellow C G, Knight K R, O'Brien B M. Prior elevation of vascular island skin flaps: intolerance to ischemia caused by venous obstruction.  J Reconstr Microsurg. 1989;  5 163-165
    PubMedGoogle Scholar
  • 12 Angel M F, Mellow C G, Knight K R, O'Brien B M. Secondary ischemia time in rodents: contrasting complete pedicle interruption with venous obstruction.  Plast Reconstr Surg. 1990;  85 789-793
    CrossrefPubMedGoogle Scholar
  • 13 Kerrigan C L, Wizman P, Hjortdal V E, Sampalis J. Global flap ischemia: a comparison of arterial versus venous etiology.  Plast Reconstr Surg. 1994;  93 1485-1495
    CrossrefPubMedGoogle Scholar
  • 14 Heden P, Sollevi A. Circulatory and metabolic events in pig island skin flaps after arterial or venous occlusion.  Plast Reconstr Surg. 1989;  84 475-481
    PubMedGoogle Scholar
  • 15 Hjortdal V E, Hansen E S, Hauge E. Myocutaneous flap ischemia: flow dynamics following venous and arterial obstruction.  Plast Reconstr Surg. 1992;  89 1083-1091
    PubMedGoogle Scholar
  • 16 Hjortdal V E, Hauge E, Hansen E S. Differential effects of venous stasis and arterial insufficiency on tissue oxygenation in myocutaneous island flaps: an experimental study in pigs.  Plast Reconstr Surg. 1992;  89 521-529
    CrossrefPubMedGoogle Scholar
  • 17 Hauge E M, Balling E, Hartmund T, Hjortdal V E. Secondary ischemia caused by venous or arterial occlusion shows differential effects on myocutaneous island flap survival and muscle ATP levels.  Plast Reconstr Surg. 1997;  99 825-833
    CrossrefPubMedGoogle Scholar
  • 18 Yucel A, Senyuva C, Andican G et al.. Secondary venous ischemic injury associated with neutrophil infiltration and lipid peroxidation: amelioration of injury by cyclosporin A in a rat inguinal island flap.  Ann Plast Surg. 2000;  45 54-60
    PubMedGoogle Scholar
  • 19 Zhang F, Lineaweaver W C, Kao S D, Tonken H, Walker R. Manual of Experimental Muscle Flap and Organ Transplantations Models in the Rat. Reading, PA; Sharpoint, Surgical Specialties Co. 1995
    Google Scholar
  • 20 Yim K, Lineaweaver W, Briones R et al.. Critical ischemia time of rat serratus anterior and gracilis muscles. In: Carraro U, Salmon S Basic and Applied Myology: Perspectives for the 90's. Padova, Italy; Unipress 1991: 373-375
    Google Scholar
  • 21 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.  Anal Biochem. 1987;  162 156-159
    PubMedGoogle Scholar
  • 22 Malizos K N, Seaber A V, Urbaniak J R. A comparative study of the effect of arterial and venous occlusion after various periods of ischemia.  J Reconstr Microsurg. 1990;  6 271-277
    PubMedGoogle Scholar
  • 23 Gabriel A, Chaney N, Stephenson L L, Zamboni W A. Effect of total venous occlusion on capillary flow and necrosis in skeletal muscle.  Plast Reconstr Surg. 2001;  108 430-433
    CrossrefPubMedGoogle Scholar
  • 24 Hjortdal V E, Sinclair T, Kerrigan C L, Solymoss S. Venous ischemia in skin flaps: microcirculatory intravascular thrombosis.  Plast Reconstr Surg. 1994;  93 366-374
    PubMedGoogle Scholar
  • 25 Cetinkale O, Bilgic L, Bolayirli M, Sengul R, Ayan F, Burcak G. Involvement of neutrophils in ischemia-reperfusion injury of inguinal island skin flaps in rats.  Plast Reconstr Surg. 1998;  102 153-160
    PubMedGoogle Scholar
  • 26 Kirschner R E, Chiao J J, Fyfe B S, Hoffman L A, Davis J M, Fantini G A. Neutrophil lipoxygenase activation and leukosequestration in postischemic myocutaneous flaps: role of LTB4.  Am J Physiol. 1995;  268 H2167-H2174
    PubMedGoogle Scholar
  • 27 Wang C, Kerrigan C L, Stotland M A. Kinetics of E-selectin expression in surgical flaps.  Plast Reconstr Surg. 1997;  100 1482-1488
    PubMedGoogle Scholar
  • 28 Stotland M A, Kerrigan C L. E- and L-selectin adhesion molecules in musculocutaneous flap reperfusion injury.  Plast Reconstr Surg. 1997;  99 2010-2020
    PubMedGoogle Scholar
  • 29 Rumalla V K, Borah G L. Cytokines, growth factors, and plastic surgery.  Plast Reconstr Surg. 2001;  108 719-733
    PubMedGoogle Scholar
  • 30 Ambrosio G, Tritto I. Reperfusion injury: experimental evidence and clinical implications.  Am Heart J. 1999;  138 S69-S75
    CrossrefPubMedGoogle Scholar
  • 31 Gamble J R, Harlan J M, Klebanoff S J, Vadas M A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.  Proc Natl Acad Sci USA. 1985;  82 8667-8671
    PubMedGoogle Scholar
  • 32 Ozer K, Adanali G, Siemionow M. Late effects of TNF-alpha-induced inflammation on the microcirculation of cremaster muscle flaps under intravital microscopy.  J Reconstr Microsurg. 2002;  18 37-45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Adanali G, Ozer K, Siemionow M M. Acute alterations in muscle flap microcirculation during tumor necrosis factor alpha-induced inflammation.  Ann Plast Surg. 2001;  47 652-659
    PubMedGoogle Scholar
  • 34 Estrov Z, Kurzrock R, Talpaz M. Interleukin-1 and its inhibitors: implications for disease biology and therapy.  Cancer Treat Res. 1995;  80 51-82
    PubMedGoogle Scholar
  • 35 Stewart R J, Marsden P A. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.  Am J Kidney Dis. 1995;  25 954-966
    PubMedGoogle Scholar
  • 36 Furuichi K, Wada T, Yokoyama H, Kobayashi K I. Role of cytokines and chemokines in renal ischemia-reperfusion injury.  Drug News Perspect. 2002;  15 477-482
    CrossrefPubMedGoogle Scholar
  • 37 Nose P S. Cytokines and reperfusion injury.  J Card Surg. 1993;  8 305-308
    PubMedGoogle Scholar
  • 38 Most D, Hoyt J, Sibley R K, Press B H. Parenchymal cytokine expression precedes clinically observed ischemia in dorsal flaps in the rat.  Plast Reconstr Surg. 1996;  98 856-861
    PubMedGoogle Scholar
  • 39 DiPietro L A, Polverini P J, Rahbe S M, Kovacs E J. Modulation of JE/MCP-1 expression in dermal wound repair.  Am J Pathol. 1995;  146 868-875
    PubMedGoogle Scholar
  • 40 Humphries J, McGuinness C L, Smith A, Waltham M, Poston R, Burnand K G. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi.  J Vasc Surg. 1999;  30 894-899
    CrossrefPubMedGoogle Scholar
  • 41 Dipietro L A, Reintjes M G, Low Q E, Levi B, Gamelli R L. Modulation of macrophage recruitment into wounds by monocyte chemoattractant protein-1.  Wound Repair Regen. 2001;  9 28-33
    CrossrefPubMedGoogle Scholar
  • 42 Frangogiannis N G. The role of the chemokines in myocardial ischemia and reperfusion.  Curr Vasc Pharmacol. 2004;  2 163-174
    CrossrefPubMedGoogle Scholar
  • 43 Naidu B V, Farivar A S, Woolley S M, Grainger D, Verrier E D, Mulligan M S. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury.  J Heart Lung Transplant. 2004;  23 128-134
    PubMedGoogle Scholar
  • 44 Kajihara N, Morita S, Nishida T et al.. Transfection with a dominant-negative inhibitor of monocyte chemoattractant protein-1 gene improves cardiac function after 6 hr of cold preservation.  Circulation. 2003;  108 II213-II218
    PubMedGoogle Scholar
  • 45 Chang J, Thunder R, Most D, Longaker M T, Lineaweaver W C. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion.  Plast Reconstr Surg. 2000;  105 148-155
    PubMedGoogle Scholar
  • 46 Kryger G S, Kryger Z, Zhang F, Shelton D L, Lineaweaver W C, Buncke H J. Nerve growth factor inhibition prevents traumatic neuroma formation in the rat.  J Hand Surg Am. 2001;  26 635-644
    PubMedGoogle Scholar

Feng ZhangM.D. Ph.D. 

Division of Plastic Surgery, University of Mississippi Medical Center

2500 North State Street, Jackson, MS 39216

      >